Plasma homeostatic chemokines CCL19 and CCL21 and the prognosis of ischemic stroke in two Chinese prospective cohorts.

European journal of neurology(2023)

引用 0|浏览7
暂无评分
摘要
Both CCL19 and CCL21 levels were independently associated with adverse outcomes within 3 months after ischemic stroke and should be further investigated for risk stratification and potential therapeutic targets of ischemic stroke.
更多
查看译文
关键词
adverse outcome, cardiovascular event, homeostatic chemokines, ischemic stroke
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要